This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Fattah Champions Neuroscience Advancements With Scientists, Thought Leaders

WASHINGTON, July 30, 2013 /PRNewswire-USNewswire/ -- Continuing his longstanding commitment to neuroscience research, Congressman Chaka Fattah (D-PA) will headline a webinar today entitled, "From Congress to Your Lab: How Federal Funding Affects Your Science." The event comes just a day after Fattah hosted a neuroscience briefing in Philadelphia in conjunction with the White House and as part of the Fattah Neuroscience Initiative (FNI).

Since becoming the lead Democrat on the Commerce, Justice and Science (CJS) subcommittee for the House Appropriations Committee, Congressman Fattah has elevated neuroscience research as a national priority.  The Fattah Neuroscience Initiative (FNI), created with support from the White House, is an innovative, non-incremental policy initiative seeking to achieve groundbreaking progress in understanding the human brain through a collaborative research approach.

Today's webinar, hosted by the Society for Neuroscience -the world's largest organization of scientists and physicians devoted to understanding the brain and nervous system, will educate scientists on effectively promoting their research efforts with Federal lawmakers. Congressman Fattah will emphasize the need for increased advocacy and engagement between scientists and Congress, citing the significance these relationships have in securing biomedical research funding.

Congressman Fattah said, "Decisions are being made today that could have an impact for generations to come. Now more than ever, we must drive home the message that cuts to biomedical research are not just bad politics, they have real and lasting impacts on groundbreaking medical research and the lives of all Americans."

On Monday, more than 40 thought leaders from throughout the Philadelphia region convened for a briefing on the current state of neuroscience research hosted by Congressman Fattah at the University City Science Center in Philadelphia. Attendees heard from Fattah and Dr. Philip Rubin, Principal Assistant Director for Science at The White House Office of Science and Technology Policy (OSTP). Dr. Rubin delivered a presentation on neuroscience and provided an update on OSTP's work and the Fattah Neuroscience Initiative highlighting the importance of public private partnerships in advancing neuroscience research.

SOURCE Office of Congressman Chaka Fattah

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs